Amid a growing concern over a second wave occurring in the country, there is heartening news for the people with sight of a potential vaccine in a couple of months. According to Adar Poonawalla, CEO of Serum Institute of India, the coronavirus vaccine could be available in India by January subject to all on-time approvals from regulatory bodies.
SII says that deliveries from AstraZeneca with whom they have tied up for the production of the vaccines are running late.
However, in an interview with a media channel Adar said a coronavirus vaccine is expected to be available in the country by January 2021 if all the approvals are taken care of despite this delayed deliveries.
The Britain-based vaccine candidate AstraZeneca said that it was holding back deliveries of its coronavirus vaccine because it is waiting for the data from late-stage clinical trials so that shelf-life of supplies across the world could be maximized. Its CEO Pascal Soriot said the coronavirus vaccine has been kept in a frozen form.
As many as 45 COVID-19 vaccine candidates are in human trials across the world, with Pfizer Inc saying it could file in late November for US authorization. It opens up the possibility of a vaccine being available in the United States by the end of the year.
A vaccine is seen as the world’s only panacea for curbing and halting the coronavirus pandemic that has infected more than 48 million people, led to more than 1.2 million deaths, crumbling economies and that disrupted billions of lives since it was first identified in China in December.